BRIEF-Vitae Pharmaceuticals says VTP-43742 demonst
Post# of 22755
March 16
Vitae Pharmaceuticals Inc :
* Vitae pharmaceuticals achieves proof-of-concept with first-in-class roryt inhibitor in moderate to severe psoriasis
* Company plans to move vtp-43742 forward into 16-week study
* Vtp-43742 demonstrated statistically significant efficacy and was well tolerated Source text for Eikon: Further company coverage:
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'